Does Aprotinin Increase the Myocardial Damage in the Setting of Ischemia and Preconditioning?
Background. Aprotinin reduces postoperative bleeding in cardiac operations, but its association with perioperative myocardial infarction remains controversial. Ischemic preconditioning is a novel method of myocardial protection. Methods. To answer whether aprotinin increases postischemic myocardial damage and also to characterize the effect of aprotinin on ischemic preconditioning, four groups of sheep were fully heparinized to keep activated clotting time readings greater than 750 seconds and subjected to 60 minutes of normothermic regional ischemia (diagonal artery occlusion) with 3 hours of reperfusion. Group I was the control with no treatment, group II received aprotinin (1 million KIU load followed by 250,000 KIU/h), group III underwent ischemic preconditioning (three 5-minute intervals of ischemia and reperfusion) before prolonged 1-hour ischemia, and group IV underwent similar ischemic preconditioning and received aprotinin. Area at risk was delineated by monastryl blue pigment
Related Questions
- Is the development of myocardial tolerance to repeated ischemia in humans due to preconditioning or to collateral recruitment?
- Does the serum cardiac troponin I level increase with stress test-induced myocardial ischemia?
- Does Aprotinin Increase the Myocardial Damage in the Setting of Ischemia and Preconditioning?
